62 II.3.1 Vision d'ensemble: ce qu'il faut savoir, p.73 ,
Diseases of the Prostate: Their Pathology and Treatment ,
Prostate-Specific Antigen as a Serum Marker for Adenocarcinoma of the Prostate, New England Journal of Medicine, vol.317, issue.15, pp.909-916, 1987. ,
DOI : 10.1056/NEJM198710083171501
AN ??? ACID ??? PHOSPHATASE OCCURRING IN THE SERUM OF PATIENTS WITH METASTASIZING CARCINOMA OF THE PROSTATE GLAND, Journal of Clinical Investigation, vol.17, issue.4, pp.473-478, 1938. ,
DOI : 10.1172/JCI100974
Significance of increase phosphatase activity of bone at the site of osteoplastic metastasis secondary to carcinoma of the prostate gland, Am J Cancer, p.28485, 1936. ,
Organ-specific antigens of liver, testicle and pituitary, J. Immunol, vol.94, pp.157-163, 1965. ,
Characterization and isolation of specific renal tubular epithelial antigens, J. Immunol. Déc, vol.99, issue.6, pp.1199-1210, 1967. ,
Studies on the Antigenic Properties of Prostatic Tissue I., The Journal of Urology, vol.84, issue.1, pp.134-143, 1960. ,
DOI : 10.1016/S0022-5347(17)65503-4
Studies on Spermagglutinating Antibodies in Antihuman Prostate Sera, The Journal of Urology, vol.87, issue.3, pp.475-478, 1962. ,
DOI : 10.1016/S0022-5347(17)64982-6
Precipitating antibody in the sera of patients treated cryosurgically for carcinoma of the prostate, Exp Med Surg, vol.27, issue.4, pp.406-410, 1969. ,
Tissue-and species-specific antigens of normal human prostatic tissue, J. Immunol, vol.104, issue.6, pp.1329-1339, 1970. ,
PRECIPITATING ANTIGENS OF THE NORMAL HUMAN PROSTATE, Reproduction, vol.22, issue.3, pp.573-574, 1970. ,
DOI : 10.1530/jrf.0.0220573
Immunologic studies of normal, benign, and malignant human prostatic tissue. Cancer, pp.1570-1574, 1972. ,
Some physico-chemical characteristics of " seminoprotein" , an antigenic component specific for human seminal plasma. Forensic immunological study of body fluids and secretion. VII], Nihon Hoigaku Zasshi, 1971. ,
Stérilité du couple. 2 éd, 2005. ,
The Sperm- and Seminal Plasma-Specific Antigens of Human Semen**Supported by Ford Foundation Grant 37482., Fertility and Sterility, vol.21, issue.7, pp.565-573, 1970. ,
DOI : 10.1016/S0015-0282(16)37627-0
Isolation and characterization of two specific antigens of human seminal plasma, Fertil. Steril. Fév, vol.24, issue.2, pp.134-144, 1973. ,
PROSTATE-SPECIFIC ANTIGEN, Urologic Clinics of North America, vol.24, issue.2, pp.253-259, 1997. ,
DOI : 10.1016/S0094-0143(05)70370-0
Isolation and Characterization of a Semen-Specific Protein from Human Seminal Plasma: A Potential New Marker for Semen Identification, Journal of Forensic Sciences, vol.23, issue.1, pp.106-115, 1978. ,
DOI : 10.1520/JFS10659J
Purification of a human prostate specific antigen, The Journal of Urology, vol.167, issue.2, pp.159-163, 1979. ,
DOI : 10.1016/S0022-5347(02)80311-1
A prostate antigen in sera of prostatic cancer patients, Cancer Res, vol.40, issue.7, pp.2428-2432, 1980. ,
Quantitation of prostate-specific antigen in serum by a sensitive enzyme immunoassay, Cancer Res. Déc, vol.40, issue.12, pp.4658-4662, 1980. ,
Prostate antigen: A new potential marker for prostatic cancer, The Prostate, vol.40, issue.1, pp.89-96, 1981. ,
DOI : 10.1002/pros.2990020109
Prostate-specific antigen, p30, ??-seminoprotein, and EI, The Prostate, vol.66, issue.2, pp.107-110, 1994. ,
DOI : 10.1111/j.1432-1033.1987.tb13674.x
Enzymatic activity of prostate-specific antigen and its reactions with extracellular serine proteinase inhibitors, European Journal of Biochemistry, vol.40, issue.3, pp.755-763, 1990. ,
DOI : 10.1016/0304-4165(83)90096-X
Prostatespecific antigen in serum occurs predominantly in complex with alpha 1-antichymotrypsin, Clin. Chem, vol.37, issue.9, pp.1618-1625, 1991. ,
A complex between prostate-specific antigen and alpha 1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer, Cancer Res, vol.51, issue.1, pp.222-226, 1991. ,
Structure and function of prostatic-and seminal vesicle-secreted proteins involved in the gelation and liquefaction of human semen. Scand, J. Clin. Lab. Invest, vol.191, pp.13-20, 1988. ,
Human prostate-specific glandular kallikrein is expressed as an active and an inactive protein, Clin. Chem, 1997. ,
Polyclonal and monoclonal antibodies to prostate-specific antigen can cross-react with human kallikrein 2 and human kallikrein 1, Urology, vol.53, issue.4, 1999. ,
DOI : 10.1016/S0090-4295(98)00573-1
Characterization of the precursor of prostate-specific antigen. Activation by trypsin and by human glandular kallikrein, J. Biol. Chem. Aoû, vol.22272, issue.34, pp.21582-21588, 1997. ,
Expression of pro form of prostatespecific antigen by mammalian cells and its conversion to mature, active form by human kallikrein 2. Cancer Res, Aoû, vol.157, issue.15, pp.3111-3114, 1997. ,
Activation of the Zymogen Form of Prostate-Specific Antigen by Human Glandular Kallikrein 2, Biochemical and Biophysical Research Communications, vol.238, issue.2, pp.549-555, 1997. ,
DOI : 10.1006/bbrc.1997.7333
COAGULATION AND LIQUEFACTION OF SEMEN: PROTEOLYTIC ENZYMES AND CITRATE IN PROSTATIC FLUID, Journal of Experimental Medicine, vol.76, issue.6, pp.527-541, 1942. ,
DOI : 10.1084/jem.76.6.527
Kallikrein 4 is a proliferative factor that is overexpressed in prostate cancer. Cancer Res, pp.5221-5230, 2007. ,
Blood levels of free-PSA but not complex-PSA significantly correlates to prostate release of PSA in semen in young men, while blood levels of complex-PSA, but not free-PSA increase with age, The Prostate, vol.48, issue.1, pp.66-72, 2005. ,
DOI : 10.1046/j.1464-410X.1998.00723.x
Measurement of circulating forms of prostate-specific antigen in whole blood immediately after venipuncture: implications for point-of-care testing, Clin. Chem. Avr, vol.47, issue.4, pp.703-711, 2001. ,
Isolation, characterization and amino-acid sequence of gamma-seminoprotein, a glycoprotein from human seminal plasma ,
Immunoreactive Prostatic Specific Antigen in Male Periurethral Glands, The Journal of Urology, vol.147, issue.1, pp.246-248, 1992. ,
DOI : 10.1016/S0022-5347(17)37206-3
Skene's Gland Adenocarcinoma with Increased Serum Level of Prostate-Specific Antigen, Gynecologic Oncology, vol.55, issue.2, pp.304-307, 1994. ,
DOI : 10.1006/gyno.1994.1294
Immunohistochemical Labelling for Prostate Specific Antigen in Non-Prostatic Tissues, Pathology - Research and Practice, vol.192, issue.3, pp.233-237, 1996. ,
DOI : 10.1016/S0344-0338(96)80226-3
Possible value of positive PSA levels in malignant and nonmalignant breast diseases]. Onkologie, Fév, vol.24, issue.1, pp.11-17, 2001. ,
Prostate specific antigen--new applications in breast and other cancers, Anticancer Res. Déc, vol.16, issue.6C, pp.3983-3984, 1996. ,
The Periurethral Glands do not Significantly Influence the Serum Prostate Specific Antigen Concentration, The Journal of Urology, vol.155, issue.5, pp.1658-1660, 1996. ,
DOI : 10.1016/S0022-5347(01)66156-1
In Situ Hybridization of Prostate-Specific Antigen mRNA in Human Prostate, The Journal of Urology, vol.144, issue.6, pp.1550-1556, 1990. ,
DOI : 10.1016/S0022-5347(17)39797-5
Le cancer de la prostate: Prise en charge de la maladie et de ses séquelles, 2007. ,
Prostate-specific antigen and prostate cancer: prediction, detection and monitoring, Nature Reviews Cancer, vol.174, issue.4, pp.268-278, 2008. ,
DOI : 10.1016/j.urolonc.2005.11.039
Twenty Years of PSA: From Prostate Antigen to Tumor Marker, Rev Urol, vol.9, issue.3, pp.113-123, 2007. ,
Ultrasensitive radioimmunoassay of prostate-specific antigen, Clin. Chem. Mai, vol.38, issue.5, pp.735-742, 1992. ,
Early Detection of Residual Prostate Cancer After Radical Prostatectomy by an Ultrasensitive Assay for Prostate Specific Antigen, The Journal of Urology, vol.149, issue.4, pp.787-792, 1993. ,
DOI : 10.1016/S0022-5347(17)36208-0
Que peut attendre le clinicien aujourd'hui du dosage du PSA ?, Immuno-analyse & Biologie Sp??cialis??e, vol.8, issue.4, pp.234-243, 1993. ,
DOI : 10.1016/S0923-2532(05)80006-7
Continuous cultures of fused cells secreting antibody of predefined specificity, Nature, vol.3, issue.5517, pp.495-497, 1975. ,
DOI : 10.1042/bj1280427
Epitope mapping of human prostate specific antigen and glandular kallikrein expressed in insect cells. Prostate Cancer Prostatic Dis, pp.16-20, 1997. ,
Multiple forms of prostatespecific antigen in serum: differences in immunorecognition by monoclonal and polyclonal assays, Clin. Chem. Déc, vol.39, issue.12, pp.2483-2491, 1993. ,
Disagreement between the Roche Cobas(R) Core and Hybritech TANDEM(R)-E PSA Assays When Measuring Free, Complexed and Total Serum Prostate Specific Antigen, Annals of Clinical Biochemistry: An international journal of biochemistry and laboratory medicine, vol.31, issue.5, pp.501-505, 1994. ,
DOI : 10.1177/000456329403100514
Measurement of Prostate-Specific Antigen in Serum as a Screening Test for Prostate Cancer, New England Journal of Medicine, vol.324, issue.17, 1991. ,
DOI : 10.1056/NEJM199104253241702
Selection of Optimal Prostate Specific Antigen Cutoffs for Early Detection of Prostate Cancer: Receiver Operating Characteristic Curves, The Journal of Urology, vol.152, issue.6, pp.2037-2042, 1994. ,
DOI : 10.1016/S0022-5347(17)32300-5
Second stanford conference on international standardization of prostate-specific antigen immunoassays: September 1 and 2, 1994, Urology, vol.45, issue.2, pp.173-184, 1994. ,
DOI : 10.1016/0090-4295(95)80001-8
Biological Variation of Total Prostate-Specific Antigen: A Survey of Published Estimates and Consequences for Clinical Practice, Clinical Chemistry, vol.51, issue.8, pp.1342-1351, 2005. ,
DOI : 10.1373/clinchem.2004.046086
Lowering PSA cutoffs to enhance detection of curable prostate cancer, Urology, vol.55, issue.6, pp.791-795, 2000. ,
DOI : 10.1016/S0090-4295(99)00602-0
Screening with low PSA cutoff values results in low rates of positive surgical margins in radical prostatectomy specimens, The Prostate, vol.164, issue.3, pp.241-245, 2002. ,
DOI : 10.1016/S0022-5347(05)67456-3
Effect of Verification Bias on Screening for Prostate Cancer by Measurement of Prostate-Specific Antigen, New England Journal of Medicine, vol.349, issue.4, 2003. ,
DOI : 10.1056/NEJMoa021659
Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4 ,
Serum concentrations of prostate specific antigen and its complex with alpha 1-antichymotrypsin before diagnosis of prostate cancer, Lancet. Déc, vol.10344, issue.8937, pp.1594-1598, 1994. ,
A Prospective Evaluation of Plasma Prostate-Specific Antigen for Detection of Prostatic Cancer, JAMA: The Journal of the American Medical Association, vol.273, issue.4, pp.289-294, 1995. ,
DOI : 10.1001/jama.1995.03520280035036
Long-Term Prediction of Prostate Cancer Up to 25 Years Before Diagnosis of Prostate Cancer Using Prostate Kallikreins Measured at Age 44 to 50 Years, Journal of Clinical Oncology, vol.25, issue.4, pp.431-436, 2007. ,
DOI : 10.1200/JCO.2006.06.9351
Restandardisation OMS des dosages PSA et PSA libre Access hybritech. Clinical News, Avr, issue.13, pp.12-13, 2007. ,
Urologie et Cancer, John Libbey Eurotext, 2004. ,
Prostate Specific Antigen in the Diagnosis and Treatment of Adenocarcinoma of the Prostate. II. Radical Prostatectomy Treated Patients, The Journal of Urology, vol.141, issue.5, pp.1076-1083, 1989. ,
DOI : 10.1016/S0022-5347(17)41175-X
Prostate-specific antigen as a marker of disease activity in prostate cancer, Oncology, 2002. ,
Prostate-Specific Antigen and the Early Diagnosis of Prostate Cancer, Pathology Patterns Reviews, vol.117, issue.suppl_1, pp.104-108, 2002. ,
DOI : 10.1309/C4UN-12LK-43HP-JXY3
Influence of Prostatic Disease and Prostatic Manipulations on the Concentration of Prostate-Specific Antigen, European Urology, vol.22, issue.1, pp.20-26, 1992. ,
DOI : 10.1159/000474716
Effects of Rectal Examination, Prostatic Massage, Ultrasonography and Needle Biopsy on Serum Prostate Specific Antigen Levels, The Journal of Urology, vol.147, issue.3, pp.810-814, 1992. ,
DOI : 10.1016/S0022-5347(17)37392-5
The Use of Prostate Specific Antigen, Clinical Stage and Gleason Score to Predict Pathological Stage in Men with Localized Prostate Cancer, The Journal of Urology, vol.150, issue.1, pp.110-114, 1993. ,
DOI : 10.1016/S0022-5347(17)35410-1
A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer, J. Natl. Cancer Inst Mai, vol.2090, issue.10, pp.766-771, 1998. ,
Combined-modality staging for localized adenocarcinoma of the prostate, Oncology Aoû, vol.15, issue.8, pp.1049-1059, 1060. ,
Screening and Prostate-Cancer Mortality in a Randomized European Study, New England Journal of Medicine, vol.360, issue.13, pp.1320-1328, 2009. ,
DOI : 10.1056/NEJMoa0810084
Meta-Analysis of Prostate-Specific Antigen and Digital Rectal Examination as Screening Tests for Prostate Carcinoma, The Journal of the American Board of Family Medicine, vol.16, issue.2, pp.95-101, 2003. ,
DOI : 10.3122/jabfm.16.2.95
Comparison of Prostate Specific Antigen Concentration Versus Prostate Specific Antigen Density in the Early Detection of Prostate Cancer: Receiver Operating Characteristic Curves, The Journal of Urology, vol.152, issue.6, pp.2031-2036, 1994. ,
DOI : 10.1016/S0022-5347(17)32299-1
Use of percentage of free prostate-specific antigen to identify men at high risk of prostate cancer when psa levels are 2.51 to 4 ng/mL and digital rectal examination is not suspicious for prostate cancer: an alternative model, Urology, vol.54, issue.2, pp.220-224, 1999. ,
DOI : 10.1016/S0090-4295(99)00185-5
PSA, PSA density, PSA density of transition zone, free/total PSA ratio, and PSA velocity for early detection of prostate cancer in men with serum PSA 2.5 to 4.0 ng/mL, Urology, vol.54, issue.3, pp.517-522, 1999. ,
DOI : 10.1016/S0090-4295(99)00153-3
Performance of a neural network in detecting prostate cancer in the prostate-specific antigen reflex range of 2.5 to 4.0 ng/mL, Urology, vol.56, issue.6, pp.1000-1006, 2000. ,
DOI : 10.1016/S0090-4295(00)00830-X
Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng/mL and benign prostate examination. Enhancement of specificity with free PSA measurements, JAMA: The Journal of the American Medical Association, vol.277, issue.18, pp.1452-1455, 1997. ,
DOI : 10.1001/jama.277.18.1452
Pathologic Characteristics of Cancers Detected in the Prostate Cancer Prevention Trial: Implications for Prostate Cancer Detection and Chemoprevention, Cancer Prevention Research, vol.1, issue.3, pp.167-173, 2008. ,
DOI : 10.1158/1940-6207.CAPR-08-0078
American Cancer Society Guidelines for the Early Detection of Cancer: Update of Early Detection Guidelines for Prostate, Colorectal, and Endometrial Cancers: ALSO: Update 2001--Testing for Early Lung Cancer Detection, CA: A Cancer Journal for Clinicians, vol.51, issue.1, pp.38-75, 2001. ,
DOI : 10.3322/canjclin.51.1.38
Incidence and Prevalence of Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia in Primary Care???The Triumph Project, European Urology, vol.42, issue.4, pp.323-328, 2002. ,
DOI : 10.1016/S0302-2838(02)00354-8
Free, Complexed and Total Serum Prostate Specific Antigen, The Journal of Urology, vol.154, issue.3, pp.1090-1095, 1995. ,
DOI : 10.1097/00005392-199509000-00051
Age-Specific Reference Ranges for Serum Prostate-Specific Antigen in Black Men, New England Journal of Medicine, vol.335, issue.5, pp.304-310, 1996. ,
DOI : 10.1056/NEJM199608013350502
Comparison of percent free PSA, PSA density, and age-specific PSA cutoffs for prostate cancer detection and staging, Urology, vol.56, issue.2, pp.255-260, 2000. ,
DOI : 10.1016/S0090-4295(00)00637-3
Estimation of prostatic growth using serial prostate-specific antigen measurements in men with and without prostate disease, Cancer Res, vol.52, issue.12, pp.3323-3328, 1992. ,
Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease, JAMA. Avr, vol.22267, issue.16, pp.2215-2220, 1992. ,
Long-Term Prediction of Prostate Cancer: Prostate-Specific Antigen (PSA) Velocity Is Predictive but Does Not Improve the Predictive Accuracy of a Single PSA Measurement 15 Years or More Before Cancer Diagnosis in a Large, Representative, Unscreened Population, Journal of Clinical Oncology, vol.26, issue.6, pp.835-841, 2008. ,
DOI : 10.1200/JCO.2007.13.1490
Assessing Prostate Cancer Risk: Results from the Prostate Cancer Prevention Trial, JNCI: Journal of the National Cancer Institute, vol.98, issue.8, 2006. ,
DOI : 10.1093/aje/kwh101
Serum Prostate Specific Antigen Complexed to ?? 1-Antichymotrypsin as an Indicator of Prostate Cancer, The Journal of Urology, vol.150, issue.1, pp.100-105, 1993. ,
DOI : 10.1016/S0022-5347(17)35408-3
Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial, JAMA Mai, vol.20279, pp.1542-1547, 1998. ,
Serum Pro Prostate Specific Antigen Improves Cancer Detection Compared to Free and Complexed Prostate Specific Antigen in Men With Prostate Specific Antigen 2 to 4 Ng/Ml, The Journal of Urology, vol.170, issue.6, pp.2181-2185, 2003. ,
DOI : 10.1097/01.ju.0000095460.12999.43
Proenzyme Forms of Prostate-Specific Antigen in Serum Improve the Detection of Prostate Cancer, Clinical Chemistry, vol.50, issue.6, pp.1017-1025, 2004. ,
DOI : 10.1373/clinchem.2003.026823
Discrimination of prostate cancer from benign disease by plasma measurement of intact, free prostate-specific antigen lacking an internal cleavage site at Lys145-Lys146, Clin. Chem. Aoû, vol.47, issue.8, pp.1415-1423, 2001. ,
Optimisation de l'utiisation du PSA. Med Nuc, pp.31-40, 2007. ,
DOI : 10.1016/j.mednuc.2007.11.004
Les perspectives des laboratoires d'analyse médicale à l'horizon 2012, 2008. ,
Inappropriate treatment of prostate cancer caused by heterophilic antibody interference, Nature Clinical Practice Urology, vol.180, issue.3, pp.164-167, 2009. ,
DOI : 10.1093/ajcp/108.4.417
CANCER OF THE PROSTATE. A CLINICAL, PATHOLOGICAL AND POST-OPERATIVE ANALYSIS OF III CASES, Annals of Surgery, vol.50, issue.6, pp.1144-1233, 1909. ,
DOI : 10.1097/00000658-190912000-00015
URL : https://hal.archives-ouvertes.fr/hal-00510976
La chirurgie du temps jadis, Cancer Info, issue.58, p.13, 1999. ,
Evaluation du plan cancer 2003-2007. Rapport final, 2009. ,
Evaluation du coût du dépistage organisé du cancer colorectal et du cancer du sein, 2007. ,
Evaluation of periodic breast cancer screening with mammography. Methodology and early observations, JAMA: The Journal of the American Medical Association, vol.195, issue.9, pp.731-738, 1966. ,
DOI : 10.1001/jama.195.9.731
Estimated benefits and risks of screening for breast cancer, Can Med Assoc J. Fév, vol.15124, issue.4, pp.399-403, 1981. ,
Ten-to fourteen-year effect of screening on breast cancer mortality, J. Natl. Cancer Inst. Aoû, vol.69, issue.2, pp.349-355, 1982. ,
Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study, N. Engl. J. Med. Mai, vol.13328, pp.1365-1371, 1993. ,
Randomised controlled trial of faecal-occult-blood screening for colorectal cancer, Lancet, 1996. ,
A Controlled Trial of a Human Papillomavirus Type 16 Vaccine, New England Journal of Medicine, vol.347, issue.21, pp.1645-1651, 2002. ,
DOI : 10.1056/NEJMoa020586
Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial, The Lancet, vol.364, issue.9447, pp.1757-1765, 2004. ,
DOI : 10.1016/S0140-6736(04)17398-4
[Principles and practice of mass screening for disease], Bol Oficina Sanit Panam, vol.65, issue.4, pp.281-393, 1968. ,
Edifice program: analysis of screening exam practices for cancer in France]. Bull Cancer, pp.1067-1073, 2008. ,
URL : https://hal.archives-ouvertes.fr/inserm-00483422
Le gouffre du cancer de la prostate. LeMonde.fr, 2010. ,
Prostate cancer screening, The Lancet, vol.357, issue.9263, pp.1-2, 2009. ,
DOI : 10.1016/S0140-6736(00)04341-5
The era of serum prostate specific antigen as a marker for biopsy of the prostate and detecting prostate cancer is now over in the USA, BJU International, vol.163, issue.7, pp.963-964, 2004. ,
DOI : 10.1097/00005392-200107000-00021
Natural history of localised prostatic cancer. A population-based study in 223 untreated patients, Lancet, 1989. ,
Long-term results of radical prostatectomy in clinically localized prostate cancer: experience at the Johns Hopkins Hospital, NCI Monogr, issue.7, pp.117-122, 1988. ,
Rapport de la première Conférence de Consensus, 1989. ,
Mortality Results from a Randomized Prostate-Cancer Screening Trial, New England Journal of Medicine, vol.360, issue.13, pp.1310-1319, 2009. ,
DOI : 10.1056/NEJMoa0810696
Evaluation et d'Accréditation en Santé. Opportunité d'un dépistage systématique du cancer de la prostate par le dosage de l'antigène spécifique de la prostate, 1999. ,
National trends in the epidemiology of prostate cancer, 1973 to 1994: evidence for the effectiveness of prostate-specific antigen screening, Urology, vol.52, issue.3, pp.444-448, 1973. ,
DOI : 10.1016/S0090-4295(98)00242-8
Screening decreases prostate cancer death: First analysis of the 1988 Quebec Prospective Randomized Controlled Trial, The Prostate, vol.80, issue.2, pp.83-91, 1999. ,
DOI : 10.1016/S0022-5347(01)67074-5
Decline in prostate cancer mortality from 1980 to 1997, and an update on incidence trends in Olmsted County ,
Cancer Surveillance Series: Interpreting Trends in Prostate Cancer??Part I: Evidence of the Effects of Screening in Recent Prostate Cancer Incidence, Mortality, and Survival Rates, JNCI Journal of the National Cancer Institute, vol.13, issue.1, pp.1017-1024, 1999. ,
DOI : 10.2165/00002512-199813010-00007
Prostate cancer: screening and early detection. Cancer Control, 2001. ,
Prostate cancer mortality after introduction of prostate-specific antigen mass screening in the Federal State of Tyrol, Austria, Urology, vol.58, issue.3, pp.417-424, 2001. ,
DOI : 10.1016/S0090-4295(01)01264-X
Radical Prostatectomy and Cystoprostatectomy with Preservation of Potency. Results Using a New Nerve-sparing Technique, British Journal of Urology, vol.4, issue.Supplement 7, pp.694-697, 1984. ,
DOI : 10.1001/archneurpsyc.1939.02270210041003
Cancer de la prostate: Recommandations du CCAFU, Prog. Urol, vol.14, issue.4, pp.913-915, 2004. ,
Cancer de la Prostate: recommandations CCAFU, Prog Urol, vol.17, pp.1159-1230, 2007. ,
Evaluation et d'Accréditation en Santé. Eléments d'information des hommes envisageant la réalisation d'un dépistage individuel du cancer de la prostate, 2004. ,
Dépistage du cancer de la prostate: de nouveaux éclairages vont contribuer à la définition de la politique publique à mettre en place, 2009. ,
Le d??pistage du cancer de la prostate en 2009??: mise au point du comit?? de canc??rologie de l???Association fran??aise d???urologie, Progr??s en Urologie, vol.20, issue.1, pp.17-23, 2010. ,
DOI : 10.1016/j.purol.2009.09.033
Prostate Cancer Mortality Reduction by Prostate-Specific Antigen???Based Screening Adjusted for Nonattendance and Contamination in the European Randomised Study of Screening for Prostate Cancer (ERSPC), European Urology, vol.56, issue.4 ,
DOI : 10.1016/j.eururo.2009.07.018
Cancer survival in five continents: a worldwide population-based study (CONCORD), The Lancet Oncology, vol.9, issue.8, pp.730-756, 2008. ,
DOI : 10.1016/S1470-2045(08)70179-7
Radical Prostatectomy Versus Watchful Waiting in Localized Prostate Cancer: the Scandinavian Prostate Cancer Group-4 Randomized Trial, JNCI Journal of the National Cancer Institute, vol.88, issue.17, pp.1144-1154, 2008. ,
DOI : 10.1093/jnci/88.17.1216
Radical prostatectomy versus watchful waiting in early prostate cancer, N. Engl. J. Med. Mai, vol.12352, pp.1977-1984, 2005. ,
Epidémiologie du cancer de la prostate. Dans: Le Cancer de la Prostate, pp.17-29, 2005. ,
Defining and updating the American Cancer Society guidelines for the cancer-related checkup: prostate and endometrial cancers, CA: A Cancer Journal for Clinicians, vol.43, issue.1, pp.42-46, 1993. ,
DOI : 10.3322/canjclin.43.1.42
Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening, JAMA. Aoû, vol.25270, issue.8, pp.948-954, 1993. ,
The Nature of Prostate Cancer Detected Through Prostate Specific Antigen Based Screening, The Journal of Urology, vol.152, issue.5, pp.1732-1736, 1994. ,
DOI : 10.1016/S0022-5347(17)32372-8
Cancer Statistics, 2004, CA: A Cancer Journal for Clinicians, vol.54, issue.1, pp.8-29, 2004. ,
DOI : 10.3322/canjclin.54.1.8
Latent carcinoma of the prostate, The Journal of Pathology and Bacteriology, vol.liii, issue.2, pp.603-616, 1954. ,
DOI : 10.1001/jama.1947.62890170001007
The Frequency of Carcinoma and Intraepithelial Neoplasia of the Prostate in Young Male Patients, The Journal of Urology, vol.150, issue.2, pp.379-385, 1993. ,
DOI : 10.1016/S0022-5347(17)35487-3
Prevalence of prostate cancer and prostatic intraepithelial neoplasia in Caucasian Mediterranean males: An autopsy study, The Prostate, vol.73, issue.Suppl, pp.238-247, 2003. ,
DOI : 10.1002/(SICI)1097-0215(19971210)73:6<808::AID-IJC6>3.0.CO;2-6
Incidence of impalpable carcinoma of the prostate and of non-malignant and precarcinomatous lesions in Greek male population: An autopsy study, The Prostate, vol.83, issue.12, pp.1319-1328, 2006. ,
DOI : 10.1080/003655900750169257-1
Localized prostate cancer. Relationship of tumor volume to clinical significance for treatment of prostate cancer, Cancer, vol.140, issue.S3, pp.933-938, 1993. ,
DOI : 10.1002/1097-0142(19930201)71:3+<933::AID-CNCR2820711408>3.0.CO;2-L
Lead Times and Overdetection Due to Prostate-Specific Antigen Screening: Estimates From the European Randomized Study of Screening for Prostate Cancer, JNCI Journal of the National Cancer Institute, vol.42, issue.5-7, pp.868-878, 2003. ,
DOI : 10.1287/mnsc.42.7.954
Contemporary Trends in Low Risk Prostate Cancer: Risk Assessment and Treatment, The Journal of Urology, vol.178, issue.3, pp.14-19, 2007. ,
DOI : 10.1016/j.juro.2007.03.135
Assessment of Pathological Prostate Cancer Characteristics in Men with Favorable Biopsy Features on Predominantly Sextant Biopsy, European Urology, vol.55, issue.3, pp.617-628, 2009. ,
DOI : 10.1016/j.eururo.2008.04.099
Prostatectomie du cancer de la prostate Intérêt de la laparoscopie par rapport aux voies chirurgicales classiques. Dans: Le Cancer de la Prostate. Ellipses, pp.145-70, 2005. ,
Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer, JAMA: The Journal of the American Medical Association, vol.271, issue.5, pp.368-374, 1994. ,
DOI : 10.1001/jama.271.5.368
Delayed Versus Immediate Surgical Intervention and Prostate Cancer Outcome, JNCI: Journal of the National Cancer Institute, vol.98, issue.5, pp.355-357, 2006. ,
DOI : 10.1056/NEJMoa043739
Active Surveillance for Favorable Risk Prostate Cancer, The Journal of Urology, vol.182, issue.6, pp.692-698, 2007. ,
DOI : 10.1016/j.juro.2009.09.038
Prostate Cancer Death of Men Treated With Initial Active Surveillance: Clinical and Biochemical Characteristics, The Journal of Urology, vol.184, issue.1, p.15, 2010. ,
DOI : 10.1016/j.juro.2010.03.041
Socioeconomic Factors and Cancer Incidence Among Blacks and Whites, JNCI Journal of the National Cancer Institute, vol.83, issue.8, pp.551-557, 1991. ,
DOI : 10.1093/jnci/83.8.551
Genetic Susceptibility to Prostate Cancer, Med Sci, vol.66, issue.2, 2004. ,
DOI : 10.1016/0140-6736(92)90927-U
BRCA2 mutation screening is clinically relevant in breast and early prostate cancer families, International Journal of Urology, vol.13, issue.5, 2007. ,
DOI : 10.1038/sj.ejhg.5200988
Family history of prostate cancer in patients with localized prostate cancer: an independent predictor of treatment outcome., Journal of Clinical Oncology, vol.15, issue.4, pp.1478-1480, 1997. ,
DOI : 10.1200/JCO.1997.15.4.1478
Association of prostate cancer family history with histopathological and clinical characteristics of prostate tumors, International Journal of Cancer, vol.167, issue.3, pp.471-474, 2005. ,
DOI : 10.1046/j.1464-410X.1998.00801.x
Population-based risk assessment for other cancers in relatives of hereditary prostate cancer (HPC) cases, The Prostate, vol.72, issue.4, pp.347-355, 2005. ,
DOI : 10.1002/pros.20248
Quantitation of GSTP1 Methylation in Non-neoplastic Prostatic Tissue and Organ-Confined Prostate Adenocarcinoma, JNCI Journal of the National Cancer Institute, vol.21, issue.4, pp.1747-1752, 2001. ,
DOI : 10.1016/0090-4295(83)90170-X
Noninvasive Detection of TMPRSS2:ERG Fusion Transcripts in the Urine of Men with Prostate Cancer, Neoplasia, vol.8, issue.10, pp.885-888, 2006. ,
DOI : 10.1593/neo.06625
DD3(PCA3)-based molecular urine analysis for the diagnosis of prostate cancer ,
A NOVEL DIAGNOSTIC TEST FOR PROSTATE CANCER EMERGES FROM THE DETERMINATION OF ??-METHYLACYL-COENZYME A RACEMASE IN PROSTATIC SECRETIONS, The Journal of Urology, vol.172, issue.3, pp.1130-1133, 2004. ,
DOI : 10.1097/01.ju.0000133560.87118.4d
PROSTATE CANCER DETECTION ON URINALYSIS FOR ?? METHYLACYL COENZYME A RACEMASE PROTEIN, The Journal of Urology, vol.172, issue.4, pp.1501-1503, 2004. ,
DOI : 10.1097/01.ju.0000137659.53129.14
Autoantibody Signatures in Prostate Cancer, New England Journal of Medicine, vol.353, issue.12, pp.1224-1235, 2005. ,
DOI : 10.1056/NEJMoa051931
RETRACTED: EPCA-2: A Highly Specific Serum Marker for Prostate Cancer, Urology, vol.69, issue.4, pp.714-720, 2007. ,
DOI : 10.1016/j.urology.2007.01.097
Nomogram prediction for prostate cancer and aggressive prostate cancer at time of biopsy: utilizing all risk factors and tumor markers for prostate cancer, Can J Urol. Avr, vol.13, issue.2, pp.2-10, 2006. ,
Guidelines for point-of-care testing. Improving patient outcomes, Am. J. Clin. Pathol, vol.104, issue.4, pp.111-127, 1995. ,
A review of near patient testing in primary care, Health Technol Assess, vol.1, issue.5, pp.1-229, 1997. ,
Relevance of the prostate-specific antigen (PSA) nanotest compared to the classical PSA test in the organized mass screening of prostate cancer, BJU International, vol.57, issue.4, pp.762-764, 2007. ,
DOI : 10.1111/j.1464-410X.2006.06701.x
Evaluation of a rapid qualitative prostate specific antigen assay, the One Step PSA(TM) test. Cancer Lett, pp.135-139, 2001. ,
Point-of-care PSA testing: an evaluation of PSAwatch, Prostate Cancer and Prostatic Diseases, vol.92, issue.3, pp.270-273, 2007. ,
DOI : 10.1111/j.1464-410X.2003.04533.x
Organic electrochemical transistor based immunosensor for prostate specific antigen (PSA) detection using gold nanoparticles for signal amplification, Biosensors and Bioelectronics, vol.25, issue.11, 20435461. ,
DOI : 10.1016/j.bios.2010.04.013
A nanoparticle label/immunochromatographic electrochemical biosensor for rapid and sensitive detection of prostate-specific antigen, Biosensors and Bioelectronics, vol.23, issue.11, pp.1659-1665, 2008. ,
DOI : 10.1016/j.bios.2008.01.037
Point-of-care fluorescence immunoassay for prostate specific antigen, Clinica Chimica Acta, vol.406, issue.1-2, pp.18-22, 2009. ,
DOI : 10.1016/j.cca.2009.04.013